Pharmacogenetic Interactions Between ABCB1 and SLCO1B1 Tagging SNPs and the Effectiveness of Statins in the Prevention of Myocardial Infarction

Overview

Journal Pharmacogenomics

Specialties Genetics
Pharmacology

Date 2010 Aug 18

PMID 20712525

Citations 20

Authors

Bas J M Peters

Andrei S Rodin

Olaf H Klungel

Cornelia M Van Duijn

Bruno H Ch Stricker

Ruben Vant Slot

Anthonius de Boer

Anke-Hilse Maitland-van der Zee

Affiliations

Soon will be listed here.

Abstract

Aims: Genetic variability within the SLCO1B1 and ABCB1 transporter genes has been associated with modification of statin effectiveness in cholesterol management.

Materials & Methods: We conducted a case-control study using a population-based registry of pharmacy records linked to the hospital discharge records. Within a hypercholesterolemic cohort, we included 668 myocardial infarction cases and 1217 controls.

Results: We tested 24 tagging SNPs and found two SNPs within ABCB1 (rs3789244, p = 0.01; rs1922242, p = 0.01) to interact with statin treatment. In addition, we found a nonsignificant haplotype-treatment interaction (p = 0.054). The odds ratio for subjects homozygous for SLCO1B1*1A was 0.49 (95% CI: 0.34-0.71) compared with 0.31 (95% CI: 0.24-0.41) for heterozygous or noncarriers of the *1A allele.

Conclusion: This is the first study to demonstrate that common genetic variability within the SLCO1B1 and ABCB1 genes is associated with the modification of the effectiveness of statins in the prevention of the clinical outcome, myocardial infarction.

Citing Articles

Transporter Genes and statin-induced Hepatotoxicity.

Choi S, Kim J, Park Y, Lee D, Park M, Yee J Cardiovasc Drugs Ther. 2024; .

PMID: 38809397 DOI: 10.1007/s10557-024-07580-2.

Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management.

Sun L, Wolska A, Amar M, Zubiran R, Remaley A J Clin Endocrinol Metab. 2023; 108(9):2424-2434.

PMID: 36929838 PMC: 10438872. DOI: 10.1210/clinem/dgad153.

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.

Megias-Vericat J, Martinez-Cuadron D, Solana-Altabella A, Poveda J, Montesinos P Pharmaceutics. 2022; 14(4).

PMID: 35456712 PMC: 9030330. DOI: 10.3390/pharmaceutics14040878.

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia.

Vanwong N, Tipnoppanon S, Na Nakorn C, Srisawasdi P, Rodcharoen P, Medhasi S Pharmgenomics Pers Med. 2022; 15:119-130.

PMID: 35210819 PMC: 8860396. DOI: 10.2147/PGPM.S346093.

The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction.

Trompet S, Postmus I, Warren H, Noordam R, Smit R, Theusch E Front Pharmacol. 2022; 12:679857.

PMID: 35069183 PMC: 8769168. DOI: 10.3389/fphar.2021.679857.